Table 1 Characteristics of the study population (N = 1342)
Creatinine clearance (CrCl) (mL/min/1.73 m2) | 54.9 ± 27.2 |
|---|---|
Iothalamate measured glomerular filtration rate (iGFR) (mL/min/1.73 m2) | 48.0 ± 19.9 |
CrCl/iGFR, mean ± SD | 1.19 ± 0.48 |
CrCl/iGFR, median (25th-75th percentile) | 1.15 (0.92-1.39) |
24-hrs urine albumin (mg/24 hrs) [median (25th-75th percentile)] | 84 (11-643) |
Age (years) | 56.2 ± 12.2 |
Male, % | 56.7% |
Physical examinations | |
Body mass index (kg/m2) | 31.3 ± 6.8 |
Body surface area (m2) | 2.0 ± 0.3 |
Systolic blood pressure (mmHg) | 129 ± 22 |
Diastolic blood pressure (mmHg) | 73 ± 13 |
Race/Ethnicity; % | |
Non-Hispanic white | 42.3% |
Non-Hispanic black | 36.8% |
Hispanic | 14.0% |
Others | 6.9% |
Self-reported comorbidities, % | |
Diabetes | 48.3% |
Cardiovascular disease | 26.4% |
Peripheral vascular disease | 5.7% |
Stroke | 8.0% |
Current smoking, % | 11.2% |
Self-reported medication use, % | |
Beta-blocker | 46.9% |
Loop diuretics | 35.3% |
Thiazide diuretics | 27.9% |
Angiotension receptor blockers or angiotensin-converting enzyme | 68.6% |
Statins | 54.2% |
Laboratory results | |
Hematocrit (%) | 37.4 ± 4.9 |
Albumin (g/dL) | 3.9 ± 0.5 |
Serum creatinine (mg/dL) | 1.61 ± 0.53 |
BUN (mg/dL) | 29 ± 13 |
Triglyceride (mg/dL) | 155 ± 112 |
LDL cholesterol (mg/dL) | 103 ± 36 |
Fasting glucose (mg/dL) | 113 ± 49 |
Hemoglobin A1C (%) | 6.6 ± 1.6 |
hs-CRP (mg/L) [median (25th-75th percentile)] | 2.2 (0.9-5.2) |